Primary outcome: Inflammatory markers (IL-6, IL-10, cortisol, CRP). Secondary outcomes: Heart rate variability (HRV). COVID-19 symptom severity. Depression and anxiety levels. Attention and memory. This evidence concerns the gene CRP and depressive symptom measurement.